跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINA RPH PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DEXMEDETOMIDINA RPH PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Approved
STANDARD
DEXMEDETOMIDINA RPH PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Rph Pharmaceuticals Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
4e0a7676545df927
Company
Rph Pharmaceuticals Ab
Type
Standard
Approval Details
Approval Id
4e0a7676545df927
Drug Cima Aemps Name
DEXMEDETOMIDINA RPH PHARMA 100 MICROGRAMOS/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN EFG
Register Number
89342
Holder Company Name
Rph Pharmaceuticals Ab
Marketing Company Name
Rph Pharmaceuticals Ab
Authorization Date
2024-02-13
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
100 microgramos/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Rph Pharmaceuticals Ab
Active Ingredients
DEXMEDETOMIDINA HIDROCLORURO
118 microgramos/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
4e0a7676545df927
Type
Standard
Back to CIMA-AEMPS Approvals